Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Other Operating Expenses (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Other Operating Expenses readings, the most recent being $62139.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses rose 1.68% to $62139.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $414264.0, a 7.44% increase, with the full-year FY2025 number at $516557.0, up 8.33% from a year prior.
  • Other Operating Expenses reached $62139.0 in Q1 2026 per CBIH's latest filing, down from $96270.0 in the prior quarter.
  • The five-year high for Other Operating Expenses was $241961.0 in Q1 2023, with the low at $56261.0 in Q3 2025.
  • A 5-year average of $134840.0 and a median of $122386.0 in 2023 define the central range for Other Operating Expenses.
  • Peak annual rise in Other Operating Expenses hit 190.92% in 2025, while the deepest fall reached 70.14% in 2025.
  • Year by year, Other Operating Expenses stood at $218680.0 in 2022, then plummeted by 52.74% to $103354.0 in 2023, then crashed by 34.78% to $67408.0 in 2024, then soared by 42.82% to $96270.0 in 2025, then crashed by 35.45% to $62139.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Other Operating Expenses are $62139.0 (Q1 2026), $96270.0 (Q4 2025), and $56261.0 (Q3 2025).